Loading...
XASX
VIT
Market cap27mUSD
Dec 05, Last price  
0.06AUD
1D
1.64%
1Q
-6.06%
IPO
-82.78%
Name

Vitura Health Ltd

Chart & Performance

D1W1MN
XASX:VIT chart
P/E
11.70
P/S
0.33
EPS
0.01
Div Yield, %
Shrs. gr., 5y
34.65%
Rev. gr., 5y
%
Revenues
124m
+5.56%
18,000447,5940123,8501,692,84066,991,732117,343,633123,870,868
Net income
4m
-74.57%
-22,341150,349-2,914,301-3,937,213-4,049,2096,048,53413,809,3893,512,378
CFO
7m
-27.92%
-20,465253,349-1,657,739-4,889,8031,067,98413,504,6699,708,3256,997,401
Dividend
Sep 04, 20230.01 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. Its brands include CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. The company was incorporated in 2018 and is based in South Yarra, Australia.
IPO date
Nov 07, 2019
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT